Temporal Trends in Statin Prescriptions and Residual Cholesterol Risk in Patients With Stable Coronary Artery Disease Undergoing Percutaneous Coronary Intervention
Paul Guedeney(Université Paris Cité), Roxana Mehran(Mount Sinai Hospital), Annapoorna Kini(Mount Sinai Medical Center), Sabato Sorrentino(Magna Graecia University), Pedro Moreno(Mount Sinai Hospital), Moritz Blum(Charité - Universitätsmedizin Berlin), George Dangas(Mount Sinai Hospital), Nitin Barman(Icahn School of Medicine at Mount Sinai), Anton Camaj(Columbia University Irving Medical Center), Joseph Sweeny(Mount Sinai Hospital), Usman Baber(Icahn School of Medicine at Mount Sinai), Jason C. Kovacic(Victor Chang Cardiac Research Institute), Ridhima Goel(Cardiovascular Institute of the South), Sherif Elsayed(Icahn School of Medicine at Mount Sinai), Rishi Chandiramani(Cardiovascular Institute of the South), Melissa Aquino(Cardiovascular Institute of the South), Bimmer E. Claessen(Columbia University Irving Medical Center)
Cited by 9
Related Papers
Clinical End Points in Coronary Stent Trials
|Circulation|2007|5.4k
From Vulnerable Plaque to Vulnerable Patient
|Circulation|2003|2.7k
From Vulnerable Plaque to Vulnerable Patient
|Circulation|2003|2.3k
Genetic Risk, Adherence to a Healthy Lifestyle, and Coronary Disease
|New England Journal of Medicine|2016|1.5k